News
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
News
HDL anti-inflammatory effects show prognostic potential
A prospective study offers new insights to questions such as why high HDL cholesterol levels aren’t always cardioprotective.
News
Medtronic recall of almost 240,000 ICDs is class I, FDA says
The recall applies to implantable defibrillators, with and without resynchronization pacing, that are at apparent risk for premature and possibly...
News
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
The strategy seemed to work in this trial: two-thirds of patients who previously rejected statins, perceiving them as the cause of muscle pain,...
News
New light cast on type 2 MI aims to sharpen diagnosis, therapy
A large survey of type 2 MI, triggered when myocardial oxygen demand outstrips supply, points to confusion hindering its diagnosis and treatment...
News
FDA expands sacubitril/valsartan indication to embrace some HFpEF
The newly approved labeling for sacubitril/valsartan (Entresto) is simply for “chronic heart failure” but almost teasingly adds, “the benefits are...
News
FDA approves orphan drug evinacumab-dgnb for homozygous FH
Indicated for homozygous familial hypercholesterolemia on top of other lipid-modifying therapy, Evkeeza (Regeneron) is a first-in-class inhibitor...
News
Myocarditis by CMR may be rare after COVID-19 in elite athletes
Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes,...
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
News
Calcium burden drives CV risk whether coronary disease is obstructive or not
That future cardiovascular risk tracks closely with plaque burden, but not so much with whether the coronary disease is obstructive, may never...
News
SAMSON pins most muscle pain experienced with statins on the nocebo effect
Some patients really do get side effects, such as muscle pain, from statins, but the trial suggests that “90% of this symptomatic burden is...
News
Omega-3 caps, vitamin D both fail for atrial fib primary prevention: VITAL-Rhythm
Neither supplement, here used as drugs, made a difference in risk for incident atrial fibrillation in the 5-year trial. And a secondary...
News
Virtual AHA 2020 may influence template for postpandemic scientific sessions
The American Heart Association has assembled a virtual meeting that retains many familiar features and formats, and even includes an address from...
News
PCI success vs. meds only in diabetes may depend on LDL-C control
PCI and LDL-lowering therapy work as a team to cut clinical risk in patients with diabetes and stable coronary disease, but succeed only if LDL-C...
News
The socioeconomic revolving door of 30-day heart failure readmissions
Racial disparities in 30-day HF readmissions stem partly from variation in economic status of residential neighborhoods, regardless of hospital...